Total Visits

Views
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis178

Total Visits Per Month

April 2019May 2019June 2019July 2019August 2019September 2019October 2019
Pembrolizumab as second-line therapy in non-small cell lung cancer in northern Norway: budget impact and expected gain—a model-based analysis1414117744

File Visits

Views
article.pdf72

Top country views

Views
United States86
Norway27
United Kingdom19
China12
France12
Canada2
Czech Republic2
Germany2
Ireland2
Italy2

Top cities views

Views
Ann Arbor33
Ashburn19
Southend19
Guangzhou6
Mountain View5
Cambridge2
Chengdu2
Dublin2
Houston2
Milan2